Skip to main content

Young Hyung Won

Hanyang University · Medicine

About the Lab

Professor Young Hyung Won's research lab focuses on translational oncology and clinical pharmacology, with a strong emphasis on molecularly targeted therapies in non-small cell lung cancer (NSCLC), particularly regarding EGFR mutations and their differential responses to tyrosine kinase inhibitors. The lab also investigates autophagy modulation as a therapeutic strategy in colorectal cancer, exploring the synergy between chemotherapeutic agents and autophagy inhibitors like chloroquine. Additionally, the lab examines clinical management challenges in special populations, such as pregnant patients with autoimmune thrombocytopenia and dialysis patients on renin-angiotensin system inhibitors, highlighting drug safety and metabolic complications in oncology and nephrology settings.

EGFR mutationsautophagy inhibitioncolorectal cancerchemotherapy toxicityclinical pharmacology

Research Overview

Papers
93
Total Citations
1,104
Papers (5y)
16
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
16total
2022
2023
2024
2025
2026
Citations per year (5y)
44total
20222023202420252026

Selected Papers

15
1
Article|98 citations·2015
A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients
Young‐Woong Won, Jungnam Joo, Tak Yun, Geon-Kook Lee, Ji‐Youn Han, Heung Tae Kim, Jin Soo Lee, Moon Soo Kim, Jong Mog Lee, Hyun‐Sung Lee, Jae Ill Zo, Sohee Kim
SJR Q1Lung Cancer
Pulmonary and Respiratory MedicineMedicine
2
Article|74 citations·2011
Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations
Young‐Woong Won, Ji‐Youn Han, Geon Kook Lee, Seog-Yun Park, Kun Young Lim, Kyong‐Ah Yoon, Tak Yun, Heung Tae Kim, Jin Soo Lee
SJR Q1Journal of Clinical Pathology

AIMS: Deletion of exon 19 of the epidermal growth factor receptor (EGFR) and mutation of exon 21 are the most common EGFR mutations and predict higher response to EGFR tyrosine kinase inhibitors (TKI). Accumulating data show clinical differences in both response and survival between these two EGFR mutations. This study investigated the clinical impact of EGFR exon 19 deletion and L858R mutation by retrospectively analysing the clinical outcome of patients with advanced non-small-cell lung cancer

Pulmonary and Respiratory MedicineMedicine
3
Article|54 citations·2012
Chloroquine enhances the chemotherapeutic activity of 5‐fluorouracil in a colon cancer cell line via cell cycle alteration
Jung‐Hye Choi, Jin Sun Yoon, Young‐Woong Won, Byeong‐Bae Park, Young Yiul Lee
SJR Q1ApmisOA

Autophagy is a conserved catabolic process that degrades cytoplasmic proteins and organelles for recycling. The role of autophagy in tumorigenesis is controversial because autophagy can be either protective or damaging to tumor cells, and its effects may change during tumor progression. A number of cancer cell lines have been exposed to chloroquine, an anti-malarial drug, with the aim of inhibiting cell growth and inducing cell death. In addition, chloroquine inhibits a late phase of autophagy.

EpidemiologyMedicine
4
Article|51 citations·2007
No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients
Sang-Woong Han, Young‐Woong Won, Joo-Hark Yi, Hwa Jung Kim
SJR Q1Nephrology Dialysis TransplantationOA

BACKGROUND: Renin-angiotensin system (RAS) blockades, angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are well accepted for the cardiorenal-protective benefits added to antihypertensive effects in chronic kidney diseases (CKD), but associated with an increased risk of hyperkalaemia. However, few studies have investigated the effect of RAS blockades on serum potassium in dialysis patients. METHODS: Hyperkalaemia associated with RAS blockades by ACEI an

Pulmonary and Respiratory MedicineMedicine
5
Article|51 citations·2005
Clinical Aspects of Pregnancy and Delivery in Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Young‐Woong Won, Won Moon, Yeong-Seop Yun, Ho-Suk Oh, Jung‐Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung‐Ju Ahn
SJR Q2The Korean Journal of Internal MedicineOA

BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) is a condition that often develops in young women and, consequently, physicians should frequently manage and monitor pregnant patients with this disorder. METHODS: We reviewed the charts of 30 women with chronic ITP delivered in 31 pregnancies from January 1995 to December 2003. RESULTS: Fifteen patients were diagnosed with ITP before pregnancy and sixteen patients were diagnosed during pregnancy. The mean platelet counts before pregnancy, du

HematologyMedicine
6
Article|45 citations·2016
Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver
JUNG-HYE CHOI, Young‐Woong Won, Hyun Sung Kim, Young‐Ha Oh, Sanghyeok Lim, H J Kim
SJR Q3Oncology LettersOA

Oxaliplatin is an effective chemotherapeutic agent for the treatment of colorectal cancer; however, it may cause liver injury, particularly sinusoidal obstruction syndrome (SOS). Although SOS does not usually present with focal lesions on radiological images, the present study describes the case of a 22-year-old woman with oxaliplatin-induced SOS mimicking metastatic colon cancer in the liver. An abdominal computed tomography revealed a novel 1 cm, low-density lesion in segment 1 of the liver fo

OncologyMedicine
7
Article|43 citations·2019
Clinical Characteristics of Clear Cell Ovarian Cancer: A Retrospective Multicenter Experience of 308 Patients in South Korea
Hee Yeon Lee, Ji Hyung Hong, Jae Ho Byun, Hee Jun Kim, Sun Kyung Baek, Jin Young Kim, Ki Hyang Kim, Jina Yun, Jung A Kim, Kwonoh Park, Hyo Jin Lee, Jung Lim Lee
SJR Q1Cancer Research and TreatmentOA

Majority of patients had early-stage and received postoperative chemotherapy regardless of stage. Early-stage and optimal debulking were identified as favorable prognostic factors. In stage IA or IB, adding adjuvant chemotherapy did not show difference in survival. Further study focusing on OCCC is required.

Reproductive MedicineMedicine
8
Article|35 citations·2019
Clinical Patterns of Continuous and Intermittent Palliative Sedation in Patients With Terminal Cancer: A Descriptive, Observational Study
Young‐Woong Won, Hye Sook Chun, Minjeong Seo, Rock Bum Kim, Jung Hoon Kim, Jung Hun Kang
SJR Q1Journal of Pain and Symptom Management
Public Health, Environmental and Occupational HealthMedicine
9
Article|29 citations·2021
Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life
Young‐Woong Won, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Sun Kyung Baek, Yu Jung Kim, Do Yeun Kim, Hyewon Ryu
SJR Q1Cancer Research and TreatmentOA

PURPOSE: In Korea, the "Act on Hospice and Palliative Care and Decisions on Life-sustaining Treatment for Patients at the End of Life" was enacted on February 4, 2018. This study was conducted to analyze the current state of life-sustaining treatment decisions based on National Health Insurance Service (NHIS) data after the law came into force. MATERIALS AND METHODS: The data of 173,028 cancer deaths were extracted from NHIS qualification data between November 2015 and January 2019. RESULTS: The

Public Health, Environmental and Occupational HealthMedicine
10
Article|29 citations·2011
Retrospective analysis of paranasal sinusitis in patients receiving hematopoietic stem cell transplantation
Young‐Woong Won, Seong Yoon Yi, Jun Ho Jang, Kihyun Kım, Seok Jin Kim, Won Seog Kim, Chul Won Jung, Dong‐Hwan Kim
SJR Q2International Journal of Hematology
OtorhinolaryngologyMedicine
11
Article|17 citations·2010
A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
Young‐Woong Won, Y.H. Park, Myung‐Ju Ahn, In‐Gu Do, Young Hyeh Ko, K. Park
SJR Q1Annals of OncologyOA
OtorhinolaryngologyMedicine
12
Article|16 citations·2011
Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)
Young‐Woong Won, Jung Hye Kwon, Soon Il Lee, Sung Yong Oh, Won Seog Kim, Seok Jin Kim, Jong-Ho Won, Kyoung Ha Kim, Seong Kyu Park, Jin Seok Kim, Cheolwon Suh, Dok Hyun Yoon
SJR Q2Annals of Hematology
Pathology and Forensic MedicineMedicine
13
Article|9 citations·2010
Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea
Young‐Woong Won, Seok Jin Kim, Kihyun Kım, Young Hyeh Ko, Won Seog Kim
SJR Q2Annals of Hematology
GeneticsMedicine
14
Article|8 citations·2004
Phase II Study of Irinotecan, 5-Fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as First-line Therapy
Young‐Woong Won, Young‐Hyo Lim, Ho-Yong Park, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung‐Ju Ahn
SJR Q1Cancer Research and TreatmentOA

BACKGROUND: The purpose of this study was to assess the efficacy and toxicity of biweekly irinotecan plus 5-fluorouracil (FU) and leucovorin (LV) in patients with relapsed or metastatic colorectal cancer. MATERIALS AND METHODS: Between March 2002 and May 2004, 24 patients with histologically confirmed relapsed or metastatic colorectal cancer were enrolled in this study. One chemotherapy cycle consisted of irinotecan 180 mg/m(2) on days 1 and 15; 5-FU 400 mg/m(2) bolus IV with 600 mg/m(2) by a 22

OncologyMedicine
15
Article|5 citations·2023
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy
Young‐Woong Won, Jin‐Hyoung Kang, Jung Hye Kwon, Dong‐Hoe Koo, Jung Hun Kang, Chi Hoon Maeng, Hee Kyung Ahn, Sung Yong Oh, Dae‐Won Lee, Joohyuk Sohn, Sarah Soyeon Oh, Kyung Hee Lee
SJR Q1Cancer Research and TreatmentOA

PURPOSE: Several previous studies and case reports have reported ethanol-induced symptoms in patients receiving anticancer drugs containing ethanol. Most docetaxel formulations contain ethanol as a solvent. However, there are insufficient data on ethanol-induced symptoms when docetaxel-containing ethanol is administered. The primary purpose of this study was to investigate the frequency and pattern of ethanol-induced symptoms during and after docetaxel administration. The secondary purpose was t

Anesthesiology and Pain MedicineMedicine

Research Areas

Pulmonary and Respiratory MedicineHematologyPathology and Forensic MedicinePublic Health, Environmental and Occupational HealthGeneticsOncology

Dive deeper into Young Hyung Won's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.